Scarica l'app Stockscreener
41.17
1.58%
0.64
Dopo l'orario di chiusura:
41.00
-0.17
-0.41%
Vtv Therapeutics Inc Borsa (VTVT) Ultime notizie
Why (VTVT) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Wall Street Analysts Think vTv Therapeutics (VTVT) Could Surge 31.58%: Read This Before Placing a Bet - sharewise.com
Millennium Management LLC Acquires Shares in vTv Therapeutics Inc - GuruFocus
VTVT Technical Analysis & Stock Price Forecast - Intellectia AI
Aug PostEarnings: How does vTv Therapeutics Inc score in quality rankingsStop Loss & AI Powered Buy and Sell Recommendations - baoquankhu1.vn
vTv Therapeutics Inc at TD Cowen Healthcare Conference Transcript - GuruFocus
Analysts’ Opinions Are Mixed on These Healthcare Stocks: vTv Therapeutics (VTVT) and CSPC Pharmaceutical Group (OtherCHJTF) - The Globe and Mail
Millennium Management (NASDAQ: VTVT) reports a 5.0% holding in vTv - Stock Titan
Technical Analysis: Will vTv Therapeutics Inc outperform the market in YEAR2026 EndofMonth & Long Hold Capital Preservation Plans - baoquankhu1.vn
How CRH plc stock performs during market volatility - baoquankhu1.vn
Aug Action: Does vTv Therapeutics Inc have declining or rising EPSEarnings Recap Report & Free Weekly Chart Analysis and Trade Guides - baoquankhu1.vn
CEO Moves: Is vTv Therapeutics Inc exposed to currency risks2026 Key Highlights & Free Fast Gain Swing Trade Alerts - baoquankhu1.vn
Understanding Momentum Shifts in (VTVT) - Stock Traders Daily
Guidance Update: Will vTv Therapeutics Inc benefit from green energy policiesInsider Selling & Real-Time Buy Zone Alerts - baoquankhu1.vn
Published on: 2026-03-23 05:09:08 - baoquankhu1.vn
vTv Therapeutics Inc. (NASDAQ:VTVT) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
VTV Therapeutics (VTVT) reports $27M 2025 net loss amid cadisegliatin advancements - MSN
VTVT Forecast, Price Target & Analyst Ratings | VTV THERAPEUTICS INC- CL A (NASDAQ:VTVT) - chartmill.com
vTv Therapeutics (VTVT) Reports $27M 2025 Net Loss Amid Cadisegliatin Advancements - Yahoo Finance
Wall Street Analysts Believe vTv Therapeutics (VTVT) Could Rally 39.86%: Here's is How to Trade - Yahoo Finance
vTv Therapeutics to Participate in the 38th Annual ROTH Conference - The Manila Times
VTv Therapeutics to Participate in the 38th Annual ROTH Conference - marketscreener.com
Biotech developing oral type 1 diabetes drug joins ROTH investor event - Stock Titan
Baker BROS. Advisors LP Has $3.46 Million Holdings in vTv Therapeutics Inc. $VTVT - MarketBeat
vTv Therapeutics (NASDAQ:VTVT) Upgraded at Evercore - MarketBeat
Wall Street Zen Upgrades vTv Therapeutics (NASDAQ:VTVT) to "Hold" - MarketBeat
HC Wainwright Raises Earnings Estimates for vTv Therapeutics - Defense World
HC Wainwright Brokers Increase Earnings Estimates for VTVT - Defense World
HC Wainwright Forecasts Higher Earnings for vTv Therapeutics - MarketBeat
This Jabil Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday - Sahm
Analysts Offer Insights on Healthcare Companies: vTv Therapeutics (VTVT) and Oxford BioMedica (OtherOXBDF) - The Globe and Mail
Evercore ISI initiates vTv Therapeutics stock with outperform rating By Investing.com - Investing.com Canada
Evercore ISI Initiates vTv Therapeutics at Outperform With $44 Price Target - marketscreener.com
Evercore ISI Initiates Coverage on VTVT with Outperform Rating | VTVT Stock News - GuruFocus
Analysts Conflicted on These Healthcare Names: MoonLake Immunotherapeutics (MLTX), Sarepta Therapeutics (SRPT) and vTv Therapeutics (VTVT) - The Globe and Mail
Research Analysts Set Expectations for VTVT Q1 Earnings - MarketBeat
vTv Therapeutics (NASDAQ:VTVT) Share Price Crosses Below 50-Day Moving AverageShould You Sell? - MarketBeat
vTv Therapeutics (VTVT) Projected to Post Earnings on Thursday - Defense World
Avoiding Lag: Real-Time Signals in (VTVT) Movement - Stock Traders Daily
BTIG Maintains Buy on vTv Therapeutics Inc (VTVT) March 11, 2026 - Meyka
BTIG reiterates Buy on vTv Therapeutics stock, $49 target maintained By Investing.com - Investing.com Canada
VTVT: BTIG Reiterates Buy Rating with Unchanged Price Target | V - GuruFocus
BTIG reiterates Buy on vTv Therapeutics stock, $49 target maintained - Investing.com
vTv Therapeutics 2025 – Pipeline, Clinical Trials, and Patent Portfolio Overview - Minichart
vTv Therapeutics price target raised to $55 from $35 at Alliance Global - TipRanks
VTv Therapeutics: Q4 Earnings Snapshot - theheraldreview.com
vTv Therapeutics Highlights Cadisegliatin Phase 3 and Cash Runway - TipRanks
vTv Therapeutics 2025 10-K: $0.0M Revenue, $(26.97)M Net Loss - TradingView
VTv Therapeutics: Fourth Quarter Earnings Overview - Bitget
vTv Therapeutics Inc 預計每股虧損 81 美分財報前瞻 - TradingView
VTV Therapeutics (VTVT) Quarterly & Annual Financial Results 2026News and Statistics - IndexBox
vTv Therapeutics (NASDAQ: VTVT) highlights cadisegliatin Phase 3 and new funding - Stock Titan
VTVT Stock Bolstered by Strong Financials and Strategic Advances - GuruFocus
vTv Therapeutics (VTVT) spotlights Phase 3 cadisegliatin and cash runway - Stock Titan
vTv Therapeutics reports Q4 EPS (58c), consensus ($1.09) - TipRanks
0.49%
1.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):